Key facts
- Notable investors include Plug and Play Tech Center, Antler, Arben Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Motley Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Motley Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Motley Bio
Developer of multiomic profiling technology designed for biological discovery, diagnostics, and disease treatment. The company integrates and analyzes diverse molecular data layers via a unified, software-driven platform, enabling life sciences and healthcare researchers to systematically capture, structure, and interpret complex biological information at scale, and improve experimental reproducibility.
- Sector
- Healthcare
- HQ
- San Mateo, CA, United States
- Employees
- 5
- Website
- motley.bio/
- Ownership
- Privately Held (backing)
Motley Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Motley Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Motley Bio in its N-PORT filings yet. We sweep new filings monthly.